Polymed adds value to a development project by selecting the optimal route to approval, whether by identifying the best therapeutic indication and means of delivery, by spotting your most effective regulatory pathway or by implementing and managing the non-clinical and clinical trials process. Polymed’s principals and consultants have extensive experience of small molecules, biologics and medical devices through having worked for many of the best known companies in the UK, the USA, Europe and Japan

Polymed has a list of recommended suppliers with whom its principals have previously worked including CROs, CMOs, analytical laboratories and professional services such as legal and patents. If a suitable supplier can not be found from within these Polymed will identify the best alternative and negotiate with it on its client’s behalf. Having negotiated the best possible price for a client Polymed passes all costs directly through to the client without adding any further margin. It makes its revenue by charging the client a project management fee or a single fee for service depending on the nature of the contract

Benefits

Polymed will :

» . Assist in the selection of viable development candidates, indications and routes of delivery
» . Identify the best non-clinical models for early proof-of-concept
» . Shorten drug and device development times by identifying the best route to approval
» . Help to extend the in-patent life and market exclusivity of the product
» . Provide a conduit to the best world experts in any given field
» . Reduce dependence on in-house expertise